KAT84NQO

Dandan Zhang1, Ming Jiang2, Kangdong Liu3

  • 1China-US (Henan) Hormel Cancer Institute, No. 127, Zhengzhou, Henan 450000, China; Institute of Trauma and Metabolism, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, China.

STAR protocols
|February 25, 2026
PubMed
概括

这项研究详细介绍了一种用于诱导食道状细胞癌 (ESCC) 的方案,该方案在小鼠中使用4-Nitroquinoline 1-oxide (4NQO). 这种方法有效地为癌症研究模拟了人类的致癌性.